PROVIDER PROFILE · NPI 1730348426

Omar ManlapazMD

EndocrinologyDuncanville, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,000

Unique beneficiaries

—

Total services

2,107

Distinct HCPCS

Medicare payment

$116K

Peer benchmark

Total Medicare services vs. 484 Endocrinology providers in TX — top quintile (cohort median 868).

PRESCRIBING · PART D · 2024

Total Rx claims

8,397

Beneficiaries

—

Total drug cost

$5.3M

Distinct drugs

Brand share

62.8%

Top prescribed drugs

Levothyroxine Sodium1,122 claims

Semaglutide837 claims

Methimazole325 claims

Dulaglutide308 claims

Metformin Hcl303 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

96.0

Cost

69.5

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

1.05%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$5K

Payment records

223

By payment type

Food and Beverage$5K

REFERRAL NETWORK

Where Omar Manlapaz's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	19	39
METHODIST HOSPITALS OF DALLAS	16	25
William Fears Internal Medicine · Duncanville, TX	15	22

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history